基于机器学习的体细胞突变发现方法
研究开发了一种基于机器学习的体细胞突变发现方法,在识别实验验证的肿瘤变异方面优于现有方法。该方法分析1368例TCGA配对肿瘤-正常外显子数据,发现74%突变调用一致,并识别出可能假阳性和假阴性变化。高质量突变调用改善了免疫检查点抑制剂治疗的黑色素瘤和肺癌患者临床结局预测。
要点
- 机器学习方法检测体细胞突变的敏感性为97%,阳性预测值为98%。
- 分析1368例TCGA样本显示74%突变调用一致,并识别出临床可操作基因中的可能假阳性和假阴性。
- 高质量突变调用改善基于肿瘤突变负荷的免疫检查点抑制剂治疗患者结局预测。
核心结论
- 基于机器学习的体细胞突变发现方法优于现有方法,可提高肿瘤变异检测准确性。
研究设计与样本
- 开发基于机器学习的体细胞突变发现方法,并与现有方法比较;分析1368例TCGA配对肿瘤-正常外显子数据。
主要发现
- 机器学习方法识别实验验证肿瘤变异的敏感性为97%,现有方法为90%至99%。
- 机器学习方法阳性预测值为98%,现有方法为34%至92%。
- 分析1368例TCGA样本显示74%突变调用一致,并识别出可能假阳性和假阴性变化,包括临床可操作基因。
- 高质量体细胞突变调用改善基于肿瘤突变负荷的黑色素瘤和肺癌患者免疫检查点抑制剂治疗结局预测。
临床怎么用
- 将高质量机器学习突变检测整合到临床下一代测序分析中,可提高检测结果准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Variability in the accuracy of somatic mutation detection may affect the discovery of alterations and the therapeutic management of cancer patients. To address this issue, we developed a somatic mutation discovery approach based on machine learning that outperformed existing methods in identifying experimentally validated tumor alterations (sensitivity of 97% versus 90 to 99%; positive predictive value of 98% versus 34 to 92%). Analysis of paired tumor-normal exome data from 1368 TCGA (The Cancer Genome Atlas) samples using this method revealed concordance for 74% of mutation calls but also identified likely false-positive and false-negative changes in TCGA data, including in clinically actionable genes. Determination of high-quality somatic mutation calls improved tumor mutation load-based predictions of clinical outcome for melanoma and lung cancer patients previously treated with immune checkpoint inhibitors. Integration of high-quality machine learning mutation detection in clinical next-generation sequencing (NGS) analyses increased the accuracy of test results compared to other clinical sequencing analyses. These analyses provide an approach for improved identification of tumor-specific mutations and have important implications for research and clinical management of cancer patients.
引用
- Wood DE, White JR, Georgiadis A, et al. A machine learning approach for somatic mutation discovery. Sci Transl Med. 2018. PMID: 30185652. doi:10.1126/scitranslmed.aar7939
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。